You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb1818856 |
---|---|
Category | Small Molecules |
Description | Eptifibatide, also co-promoted by Schering-Plough/Essex, is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class. Eptifibatide is a cyclic heptapeptide derived from a protein found in the venom of the southeastern pygmy rattlesnake (Sistrurus miliarius barbouri). It belongs to the class of the arginin-glycin-aspartat-mimetics and reversibly binds to platelets. Eptifibatide has a short half-life. The drug is the third inhibitor of GPIIb/IIIa that has found broad acceptance after the specific antibody abciximab and the non-peptide tirofiban entered the global market. |
CAS Number | [1248559-53-6] |
MW | 892.01 |
SMILES | NC(NCCCC[C@@H]1NC(CCSSC[C@@H](C(N)=O)NC([C@@H]2CCCN2C([C@@H](NC([C@@H](NC(CNC1=O)=O)CC(O)=O)=O)Cc(c[nH]3)c4c3cccc4)=O)=O)=O)=N |
Formula | C37H53N11O11S2 |
Note | For research use only |
Expiration Date | 12 months from date of receipt. |
99.87% | |
881997-86-0 | |
C35H49N11O9S2·xC2H4O2 |
Filter by Rating